Printer Friendly
The Free Library
21,436,143 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advisory committee to consider safety of cough and cold drug use in children.

FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 announced that on Oct. 18-19, the Nonprescription non·pre·scrip·tion
adj.
Sold legally without a physician's prescription; over-the-counter.
 Drugs Advisory Committee will discuss the safety and effectiveness of cough cough, sudden, forceful expiration of air from the lungs caused by an involuntary contraction of the muscles controlling the process of breathing. The cough is a response to some irritating condition such as inflammation or the presence of mucus (sputum) in the  and cold drug product use in children, the agency stated Aug. 15.

Questions have been raised about the safety of these products and whether the benefits justify any potential risks from the use of these products in children, especially in children under two years of age.

In preparation for the meeting, FDA is reviewing safety and efficacy data for the ingredients of these products.

Some reports of serious adverse events associated with the use of these products appear to be the result of giving too much of these medicines to children. An over-the-counter cough and cold medicine can be harmful if more than the recommended amount is used, if it is given too often, or if more than one cough and cold medicine containing the same active ingredient An active ingredient, also active pharmaceutical ingredient (or API), is the substance in a drug that is pharmaceutically active. Some medications may contain more than one active ingredient.  are being used.

To avoid giving a child too much medicine, parents must carefully follow the directions for use of the product in the "Drug Facts" box on the package label. The Public Health Advisory offers parents and caregivers of children recommendations when using cough and cold products in children.

Read the complete MedWatch MedWatch is the Food and Drug Administration’s reporting system for adverse events. An adverse event is any undesirable experience associated with the use of a medical product.  2007 Safety summary, including a link to FDA Public Health Advisory and Federal Register Meeting Notice regarding this issue at: http://www.fda.gov/medwatch/safety/2007/safetyO7.htm#Cough.
COPYRIGHT 2007 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Advisory Committees
Publication:Adverse Event Reporting News
Article Type:Brief article
Geographic Code:1USA
Date:Aug 27, 2007
Words:231
Previous Article:Heart drug may lead to pacemaker use in women.
Next Article:FDA committee will review Trasylol safety.
Topics:



Related Articles
Infant deaths associated with cold medications.
FDA directs ADHD drug manufacturers to notify patients about adverse events.
FDA advisory committees conclude OTC cold drugs should not be used in children under 6.
FDA safety reviewers want warnings on cold medicines for kids.
Cough, cold meds not for young children.
FDA releases recommendations on OTC cough and cold products.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles